-
2
-
-
0033608466
-
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
-
Aithal GP, Day CP, Kesteven PJL and Daly AK. 1999. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353: 111-119
-
(1999)
Lancet
, vol.353
, pp. 111-119
-
-
Aithal, G.P.1
Day, C.P.2
Kesteven, P.J.L.3
Daly, A.K.4
-
3
-
-
0036434235
-
Validation of new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population
-
Burian M, Grosch S, Tegeder I and Geisslinger G. 2002. Validation of new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German population. British Journal of Clinical Pharmacology 54: 518-521
-
(2002)
British Journal of Clinical Pharmacology
, vol.54
, pp. 518-521
-
-
Burian, M.1
Grosch, S.2
Tegeder, I.3
Geisslinger, G.4
-
4
-
-
0037565623
-
Pharmacogenetics of oral anticoagulants
-
Daly Ann K and King BP. 2003. Pharmacogenetics of oral anticoagulants. Pharmacogenetics 13: 247-252
-
(2003)
Pharmacogenetics
, vol.13
, pp. 247-252
-
-
Daly Ann, K.1
King, B.P.2
-
5
-
-
0034921210
-
Identification and functional characterization of new CYP2C9 variant (CYP2C9*5) expressed among African Americans
-
Dickmann LJ, Rettie AE, Kneller MB, Kim RB, Wood AJJ, Stein CM, Wilkinson GR and Schwarz UTEI. 2001. Identification and functional characterization of new CYP2C9 variant (CYP2C9*5) expressed among African Americans. Molecular Pharmacology 60: 382-387
-
(2001)
Molecular Pharmacology
, vol.60
, pp. 382-387
-
-
Dickmann, L.J.1
Rettie, A.E.2
Kneller, M.B.3
Kim, R.B.4
Wood, A.J.J.5
Stein, C.M.6
Wilkinson, G.R.7
Schwarz, U.T.E.I.8
-
6
-
-
0034792584
-
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
-
Goldstein JA. 2001. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. British Journal of Clinical Pharmacology 52: 349-355
-
(2001)
British Journal of Clinical Pharmacology
, vol.52
, pp. 349-355
-
-
Goldstein, J.A.1
-
7
-
-
0034051119
-
Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: Genetic analysis of the CYP2C9 locus
-
Imai Jun, Ieiri Ichiro, Mamiya Kohsuke, Miyahara Sayaka, Furuumi Hiroyasu, Nanba Eiji, Yamane Masayuki, Fukumaki Yasuyuki, Ninomiya Hideaki, Tashiro Nobutada, Otsubo Kenji and Higuchi Shin. 2000. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus. Pharmacogenetics 10: 85-89
-
(2000)
Pharmacogenetics
, vol.10
, pp. 85-89
-
-
Jun, I.1
Ichiro, I.2
Kohsuke, M.3
Sayaka, M.4
Hiroyasu, F.5
Eiji, N.6
Masayuki, Y.7
Yasuyuki, F.8
Hideaki, N.9
Nobutada, T.10
Kenji, O.11
Shin, H.12
-
8
-
-
0035217171
-
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin
-
Kidd RS, Curry TB, Gallagher S, Edeki T, Blaisdell J and Goldstein JA. 2001. Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics 11: 803-808
-
(2001)
Pharmacogenetics
, vol.11
, pp. 803-808
-
-
Kidd, R.S.1
Curry, T.B.2
Gallagher, S.3
Edeki, T.4
Blaisdell, J.5
Goldstein, J.A.6
-
9
-
-
0036263813
-
Cytochrome P450 2C9 polymorphisms: A comprehensive review of the in-vitro and human data
-
Lee CR, Goldstein JA and Pieper JA. 2002. Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 12: 251-263
-
(2002)
Pharmacogenetics
, vol.12
, pp. 251-263
-
-
Lee, C.R.1
Goldstein, J.A.2
Pieper, J.A.3
-
10
-
-
0035889154
-
Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients
-
Leung AYH, Chow HCH, Kwong YL, Lie AKW, Fung ATK, Chow WH, Yip ASB and Liang R. 2001. Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients. Blood 98: 2584-2587
-
(2001)
Blood
, vol.98
, pp. 2584-2587
-
-
Leung, A.Y.H.1
Chow, H.C.H.2
Kwong, Y.L.3
Lie, A.K.W.4
Fung, A.T.K.5
Chow, W.H.6
Yip, A.S.B.7
Liang, R.8
-
11
-
-
17944366735
-
Interindividual variability in sensitivity to warfarin - Nature or nurture?
-
Loebstein R, Yonath H, Peleg D, Almog S, Rotenberg M, Lubetsky A, Roitelman J, Harats D, Halkin H and Ezra D. 2001. Interindividual variability in sensitivity to warfarin - Nature or nurture? Clinical Pharmacology & Therapeutics 70: 159-164
-
(2001)
Clinical Pharmacology & Therapeutics
, vol.70
, pp. 159-164
-
-
Loebstein, R.1
Yonath, H.2
Peleg, D.3
Almog, S.4
Rotenberg, M.5
Lubetsky, A.6
Roitelman, J.7
Harats, D.8
Halkin, H.9
Ezra, D.10
-
12
-
-
0024284028
-
A simple salting out procedure for extracting DNA from human nucleated cells
-
Miller SA, Dykes DD, and Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16: 1215
-
(1988)
Nucleic Acids Research
, vol.16
, pp. 1215
-
-
Miller, S.A.1
Dykes, D.D.2
Polesky, H.F.3
-
13
-
-
0031840217
-
Genetic polymorphism of cytochrome P450s, CYP2C19 and CYP2C9 in a Japanese population
-
Miyuki K, Ichiro I, Koshuke M, Akinori U, and Shun H. 1998. Genetic polymorphism of cytochrome P450s, CYP2C19 and CYP2C9 in a Japanese population. Therapeutic Drug Monitoring 20: 243-247
-
(1998)
Therapeutic Drug Monitoring
, vol.20
, pp. 243-247
-
-
Miyuki, K.1
Ichiro, I.2
Koshuke, M.3
Akinori, U.4
Shun, H.5
-
14
-
-
0030868490
-
Genetic analysis of CYP2C9 polymorphism in a Japanese population
-
Nasu K, Kubota T, and Ishizaki T. 1997. Genetic analysis of CYP2C9 polymorphism in a Japanese population. Pharmacogenetics 7: 405-409
-
(1997)
Pharmacogenetics
, vol.7
, pp. 405-409
-
-
Nasu, K.1
Kubota, T.2
Ishizaki, T.3
-
15
-
-
0034799608
-
Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and black African population
-
Scordo MG, Aklillu E, Yasar U, Dahl ML, Spina E and Ingelman-Sundberg M. 2001. Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and black African population. British Journal of Clinical Pharmacology 54: 447-450
-
(2001)
British Journal of Clinical Pharmacology
, vol.54
, pp. 447-450
-
-
Scordo, M.G.1
Aklillu, E.2
Yasar, U.3
Dahl, M.L.4
Spina, E.5
Ingelman-Sundberg, M.6
-
16
-
-
0029798351
-
Genetic analysis of the human cytochrome P450 CYP2C9 locus
-
Stubbins MJ, Harries LW, Smith G, Michael H. Tarbit and Wolf CR. 1996. Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics; 6: 429-439
-
(1996)
Pharmacogenetics
, vol.6
, pp. 429-439
-
-
Stubbins, M.J.1
Harries, L.W.2
Smith, G.3
Tarbit, M.H.4
Wolf, C.R.5
-
17
-
-
0032819729
-
Frequency of cytochrome P450 variants in a Turkish population and functional relevance for phenytoin
-
Sukru AA, Brockmoller J, Bauer S, Sachse C, Guzelbey P, Ongen Z, Muradiye N and Ivar R. 1999. Frequency of cytochrome P450 variants in a Turkish population and functional relevance for phenytoin. British Journal of Clinical Pharmacology 48: 409-415
-
(1999)
British Journal of Clinical Pharmacology
, vol.48
, pp. 409-415
-
-
Sukru, A.A.1
Brockmoller, J.2
Bauer, S.3
Sachse, C.4
Guzelbey, P.5
Ongen, Z.6
Muradiye, N.7
Ivar, R.8
-
18
-
-
0029658591
-
The role of the CYP2C9-Lue 359 allelic variant in the tolbutamide polymorphism
-
Sullivan-Klose TH, Ghanayem BI, Bell DA, Zhang ZY, Kaminsky LS, Shenfield GM, Miners JO, Birkett DJ and Goldstein JA. 1996. The role of the CYP2C9-Lue 359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics 6: 341-349
-
(1996)
Pharmacogenetics
, vol.6
, pp. 341-349
-
-
Sullivan-Klose, T.H.1
Ghanayem, B.I.2
Bell, D.A.3
Zhang, Z.Y.4
Kaminsky, L.S.5
Shenfield, G.M.6
Miners, J.O.7
Birkett, D.J.8
Goldstein, J.A.9
-
19
-
-
0034872136
-
Pharmacogenetics of warfarin elimination and its clinical implications
-
Takahashi H and Echizen H. 2001. Pharmacogenetics of warfarin elimination and its clinical implications. Clinical Pharmacokinetics 40: 587-603
-
(2001)
Clinical Pharmacokinetics
, vol.40
, pp. 587-603
-
-
Takahashi, H.1
Echizen, H.2
-
20
-
-
0034283762
-
Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment
-
Taube J, Halsall D and Baglin T. 2000. Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment. Blood 96: 1816-1819
-
(2000)
Blood
, vol.96
, pp. 1816-1819
-
-
Taube, J.1
Halsall, D.2
Baglin, T.3
-
22
-
-
0028861660
-
Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
-
Wang SL, Huang JD, Lai MD and Tsai JJ. 1995. Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmacogenetics 5: 37-42
-
(1995)
Pharmacogenetics
, vol.5
, pp. 37-42
-
-
Wang, S.L.1
Huang, J.D.2
Lai, M.D.3
Tsai, J.J.4
-
23
-
-
0035040841
-
Frequency of cytochrome P4502C9 mutant alleles in a Korean population
-
Yoon YR, Shon JH, Kim MK, Lim YC, Lee HR, Park JY, Cha IJ and Shin JG. 2001. Frequency of cytochrome P4502C9 mutant alleles in a Korean population. British Journal of Clinical Pharmacology 51: 277-280
-
(2001)
British Journal of Clinical Pharmacology
, vol.51
, pp. 277-280
-
-
Yoon, Y.R.1
Shon, J.H.2
Kim, M.K.3
Lim, Y.C.4
Lee, H.R.5
Park, J.Y.6
Cha, I.J.7
Shin, J.G.8
|